IRESSA Side Effects

7022257-3 | Liver Function Test Abnormal
on Sep 22, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Iressa dosage: .

7020440-4 | Renal Failure
Patient was taking Iressa (View Usage). Patient had the following side effects: renal failure on Sep 20, 2010 from GERMANY Additional patient health information: Female patient , weighting 233.7 lb, was diagnosed with bronchial carcinoma and. Iressa dosage: . Patient was hospitalized.

7020421-0 | Liver Function Test Abnormal
Adverse event was reported on Sep 21, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 63 years of age, After Iressa was administered, patient had the following side effects: liver function test abnormal.

7014386-5 | Gastrointestinal Perforation
on Sep 21, 2010 Male patient from JAPAN , 81 years of age, weighting 143.3 lb, was diagnosed with bronchioloalveolar carcinoma, hypertension, atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, sputum retention and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation. Iressa dosage: . During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), TENORMIN (View Tenormin Review and Tenormin Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), SUNRYTHM (View Sunrythm Review and Sunrythm Label ), PLAVIX (Daily) (View Plavix Review and Plavix Label ), FLIVAS (View Flivas Review and Flivas Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CLEANAL (View Cleanal Review and Cleanal Label ).


7014385-3 | Pyrexia
on Sep 17, 2010 Male patient from CHINA , 70 years of age, was diagnosed with non-small cell lung cancer, pleural effusion and was treated with Iressa (View Usage). Patient had the following side effects: pyrexia. Iressa dosage: . During the same period patient was treated with HIGH POLY STAPHYLOCOCCIN (View High Poly Staphylococcin Review and High Poly Staphylococcin Label ). Patient was hospitalized.

7012196-6 | Paronychia
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: paronychia on Sep 15, 2010 from CHINA Additional patient health information: Male patient , 50 years of age, was diagnosed with non-small cell lung cancer, lung neoplasm malignant and. Iressa dosage: . During the same period patient was treated with HERBAL NERVE TONIC LIQUID (View Herbal Nerve Tonic Liquid Review and Herbal Nerve Tonic Liquid Label ). Patient was hospitalized.

7011861-4 | Liver Function Test Abnormal
Adverse event was reported on Sep 14, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: CANADA , 79 years of age, Patient experienced the following unwanted or unexpected effects: liver function test abnormal.

6992529-7 | Haemoptysis
on Sep 09, 2010 Male patient from JAPAN , 70 years of age, was treated with Iressa (View Usage). Patient had the following side effects: haemoptysis. Iressa dosage: . Patient was hospitalized.

6992305-5 | Acne, Headache
on Sep 08, 2010 Female patient from INDONESIA , 42 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: acne (What is acne?), headache (What is headache?). Iressa dosage: .

6992304-3 | Hepatic Function Abnormal
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Sep 08, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: .

6992303-1 | Hepatic Function Abnormal
Adverse event was reported on Sep 08, 2010 by a Female patient taking Iressa (View Usage) (Dosage: Suspended Twice, Thereafter, Alternate-day Administration) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 59 years of age, Patient had the following side effects: hepatic function abnormal.

6992300-6 | Hepatic Function Abnormal, Rash
on Sep 09, 2010 Female patient from JAPAN , 78 years of age, weighting 112.4 lb, was diagnosed with lung adenocarcinoma, neurosis, reflux oesophagitis, neuropathy peripheral, diarrhoea and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: hepatic function abnormal, rash (What is rash?). Iressa dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), TAGAMET (View Tagamet Review and Tagamet Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ). Patient was hospitalized and became disabled.

6992144-5 | Delirium, Hallucination, Muscle Rigidity, Parkinsonism, Torticollis, Tremor
on Sep 08, 2010 Male patient from JAPAN , 78 years of age, was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, hallucination, muscle rigidity, parkinsonism, torticollis, tremor. Iressa dosage: .

6988870-4 | Henoch-schonlein Purpura
Patient was taking Iressa (View Usage). Patient had the following side effects: henoch-schonlein purpura on Sep 07, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma, hypertension and. Iressa dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6988804-2 | Hepatic Function Abnormal
Adverse event was reported on Sep 08, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 40 years of age, After Iressa was administered, patient had the following side effects: hepatic function abnormal. Patient was hospitalized.

6980093-8 | Liver Function Test Abnormal
on Sep 06, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Iressa dosage: .

6978438-8 | Liver Function Test Abnormal
on Sep 06, 2010 Female patient from JAPAN , 72 years of age, weighting 103.6 lb, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: liver function test abnormal. Iressa dosage: .

6978329-2 | Suicide Attempt
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: suicide attempt on Sep 08, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with lung adenocarcinoma and. Iressa dosage: .

6978327-9 | Dyspnoea, Malaise, Pneumonitis, Pulmonary Alveolar Haemorrhage
Adverse event was reported on Sep 08, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, malaise, pneumonitis, pulmonary alveolar haemorrhage.

6976295-7 | Diarrhoea, Lung Disorder
on Sep 07, 2010 Female patient from JAPAN , weighting 92.59 lb, was diagnosed with lung adenocarcinoma, pain (What is pain?), decreased appetite, diarrhoea, oedema and was treated with Iressa (View Usage). Patient had the following side effects: diarrhoea, lung disorder. Iressa dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), LOPEMIN (View Lopemin Review and Lopemin Label ), RINDERON (View Rinderon Review and Rinderon Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6976285-4 | Hepatic Function Abnormal, Interstitial Lung Disease
on Sep 01, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: hepatic function abnormal, interstitial lung disease. Iressa dosage: .

6976152-6 | Liver Disorder
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Sep 02, 2010 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

6976149-6 | Ventricular Fibrillation
Adverse event was reported on Aug 30, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) . Location: JAPAN , 62 years of age, Patient had the following side effects: ventricular fibrillation.

6976060-0 | Convulsion, Depressed Level Of Consciousness, Diarrhoea, Dizziness, Vomiting
on Sep 06, 2010 Female patient from JAPAN , 60 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: convulsion, depressed level of consciousness, diarrhoea, dizziness (What is dizziness?), vomiting. Iressa dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6976026-0 | Duodenal Perforation
on Sep 01, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal perforation. Iressa dosage: .

6972587-6 | Acne, Headache, Insomnia
Patient was taking Iressa (View Usage). Patient had the following side effects: acne (What is acne?), headache (What is headache?), insomnia on Aug 31, 2010 from INDONESIA Additional patient health information: Female patient , 42 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and. Iressa dosage: .

6970070-5 | Ventricular Fibrillation
Adverse event was reported on Aug 30, 2010 by a Male patient taking Iressa (View Usage) (Dosage: ) . Location: JAPAN , 62 years of age, After Iressa was administered, patient had the following side effects: ventricular fibrillation.

6967520-7 | Hepatic Function Abnormal, Rash
on Aug 26, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, rash (What is rash?). Iressa dosage: . During the same period patient was treated with DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), TAGAMET (View Tagamet Review and Tagamet Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ). Patient was hospitalized and became disabled.

6967506-2 | Glomerulonephritis Rapidly Progressive, Hepatic Function Abnormal
on Aug 27, 2010 Male patient from JAPAN , 78 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer, eczema (What is eczema?), photosensitivity reaction, hypertension and was treated with Iressa (View Usage). Patient had the following side effects: glomerulonephritis rapidly progressive, hepatic function abnormal. Iressa dosage: . During the same period patient was treated with TALION (View Talion Review and Talion Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CELTECT (View Celtect Review and Celtect Label ), ATARAX (View Atarax Review and Atarax Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ). Patient was hospitalized.

6962325-5 | Pneumothorax
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: pneumothorax on Aug 24, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with lung neoplasm malignant and. Iressa dosage: . Patient was hospitalized.

6960230-1 | Liver Function Test Abnormal
Adverse event was reported on Aug 23, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 63 years of age, Patient experienced the following unwanted or unexpected effects: liver function test abnormal.

6960217-9 | Liver Function Test Abnormal
on Aug 23, 2010 Female patient from JAPAN , 72 years of age, weighting 103.6 lb, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: liver function test abnormal. Iressa dosage: .

6955251-9 | Diarrhoea
on Aug 19, 2010 Female patient from JAPAN , 70 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer, hypertension, enterocolitis, cancer pain and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: diarrhoea. Iressa dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DECADRON (View Decadron Review and Decadron Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LAC B (View Lac-b Review and Lac-b Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6945097-X | Convulsion, Depressed Level Of Consciousness, Diarrhoea, Dizziness, Vomiting
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, depressed level of consciousness, diarrhoea, dizziness (What is dizziness?), vomiting on Aug 25, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with non-small cell lung cancer and. Iressa dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6944675-1 | Lung Disorder
Adverse event was reported on Aug 23, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma, cough, constipation (What is constipation?), gastritis, pain (What is pain?), insomnia and. Location: JAPAN , 60 years of age, weighting 134.5 lb, Patient had the following side effects: lung disorder. During the same period patient was treated with CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), HEAVY MAGNESIUM OXIDE (View Heavy Magnesium Oxide Review and Heavy Magnesium Oxide Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DUROTEP (View Durotep Review and Durotep Label ), OPSO (View Opso Review and Opso Label ), LENDORMIN D (View Lendormin D Review and Lendormin D Label ), TOCLASE (View Toclase Review and Toclase Label ).

6942211-7 | Pneumatosis Intestinalis
on Aug 17, 2010 Male patient from JAPAN , 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: pneumatosis intestinalis. Iressa dosage: . Patient was hospitalized.

6940164-9 | Haemothorax, Paronychia, Renal Disorder
on Aug 18, 2010 Male patient from JAPAN , 57 years of age, weighting 136.7 lb, was diagnosed with lung adenocarcinoma, cancer pain, chronic obstructive pulmonary disease, gastric ulcer, rhinitis allergic, hypertension and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: haemothorax, paronychia, renal disorder. Iressa dosage: . During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), OMEPRAL (View Omepral Review and Omepral Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ALLELOCK (View Allelock Review and Allelock Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), OXINORM (View Oxinorm Review and Oxinorm Label ). Patient was hospitalized.

6938437-9 | Dermatitis Acneiform, Henoch-schonlein Purpura
Patient was taking Iressa (View Usage). Patient had the following side effects: dermatitis acneiform, henoch-schonlein purpura on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 50 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and. Iressa dosage: . Patient was hospitalized.

6933652-2 | Dermatitis Acneiform, Henoch-schonlein Purpura
Adverse event was reported on Aug 11, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: JAPAN , 52 years of age, weighting 108.0 lb, After Iressa was administered, patient had the following side effects: dermatitis acneiform, henoch-schonlein purpura. Patient was hospitalized.

6932655-1 | Alanine Aminotransferase Increased
on Aug 12, 2010 Male patient from HONG KONG , 63 years of age, was diagnosed with lung neoplasm malignant and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased. Iressa dosage: .

6932048-7 | Erythema, Impetigo
on Aug 10, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with lung adenocarcinoma and was treated with Iressa (View Usage). Patient had the following side effects: erythema, impetigo (What is impetigo?). Iressa dosage: . Patient was hospitalized.

6930326-9 | Dermatitis Acneiform, Henoch-schonlein Purpura
Patient was taking Iressa (View Usage). After Iressa was administered, patient had the following side effects: dermatitis acneiform, henoch-schonlein purpura on Aug 11, 2010 from JAPAN Additional patient health information: Female patient , 52 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and. Iressa dosage: . Patient was hospitalized.

6930118-0 | Alopecia, Cough, Diarrhoea, Dizziness, Dyspnoea, Hair Growth Abnormal, Piloerection, Productive Cough, Rash
Adverse event was reported on Aug 06, 2009 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , 58 years of age, weighting 184.1 lb, Patient experienced the following unwanted or unexpected effects: alopecia, cough, diarrhoea, dizziness (What is dizziness?), dyspnoea, hair growth abnormal, piloerection, productive cough, rash (What is rash?). During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ), PAIN PILL (View Pain Pill Review and Pain Pill Label ), MEGESTROL (View Megestrol Review and Megestrol Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6930114-3 | Cough, Hair Growth Abnormal
on Aug 06, 2009 Female patient from UNITED STATES , 57 years of age, was treated with Iressa (View Usage). Patient had the following side effects: cough, hair growth abnormal. Iressa dosage: .

6930113-1 | Alopecia
on Jul 01, 2009 Female patient from UNITED STATES , 70 years of age, weighting 115.1 lb, was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: alopecia. Iressa dosage: .

6930112-X | Skin Fissures
Patient was taking Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: skin fissures on Oct 01, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with lung neoplasm malignant and. Iressa dosage: .

6930111-8 | Dry Skin, Dyspnoea, Fungal Infection, Pulmonary Oedema, Rash Pruritic
Adverse event was reported on Feb 02, 2010 by a Female patient taking Iressa (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 82 years of age, weighting 160.1 lb, Patient had the following side effects: dry skin, dyspnoea, fungal infection (What is fungal infection?), pulmonary oedema, rash pruritic. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), CLARINEX (View Clarinex Review and Clarinex Label ), VITAMINS (View Vitamins Review and Vitamins Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6930110-6 | Nausea
on Nov 23, 2009 Female patient from UNITED STATES , 52 years of age, was diagnosed with pain (What is pain?) and was treated with Iressa (View Usage). After Iressa was administered, patient had the following side effects: nausea (What is nausea?). Iressa dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ).

6930107-6 | Diarrhoea, Dry Skin, Gastrooesophageal Reflux Disease
on Mar 01, 2010 Female patient from UNITED STATES , 68 years of age, weighting 96.12 lb, was diagnosed with non-small cell lung cancer, hypertension, hypokalaemia and was treated with Iressa (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dry skin, gastrooesophageal reflux disease. Iressa dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6930106-4 | Bowel Movement Irregularity, Rash
Patient was taking Iressa (View Usage). Patient had the following side effects: bowel movement irregularity, rash (What is rash?) on Jul 08, 2009 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 183.0 lb, was diagnosed with adenocarcinoma, lung neoplasm malignant, hypertension and. Iressa dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMINS (View Vitamins Review and Vitamins Label ), METAMUCIL 2 (View Metamucil-2 Review and Metamucil-2 Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), BENADRYL (View Benadryl Review and Benadryl Label ).